Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin®) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae

Pediatric Infectious Disease Journal

Volumn 17, Issue 10, 1998, Pages 963-968

  Bottenfield, Gerald W ^a   Burch, Daniel J ^a   Hedrick, James A ^a   Schaten, Robin ^a   Rowinski, Carolyn A ^a   Davies, John T ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Acute otitis media; Amoxicillin clavulanate; Drug resistant Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ABDOMINAL PAIN; ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTACT DERMATITIS; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ACUTE DISEASE; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CHILD; CHILD, PRESCHOOL; DIARRHEA; DOUBLE-BLIND METHOD; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; GASTROENTERITIS; HUMANS; INFANT; MALE; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031733291     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199810000-00041     Document Type: Conference Paper

References (14)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
2. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96.
3. Schito G, Mannelli S, Pesce A. Trends in the activity of macrolide and beta-lactam antibiotic resistance development. J Chemother 1997;9(Suppl 3):18-28.
4. Jacobs M. Susceptibility of S. pneumoniae and H. influenzae to oral agents: results of two 1997 surveys. Presentation A21. Presented at the meeting of the American Society for Microbiology, 1998.
5. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15:255-9.
6. Craig WA. The future: can we learn from the past? Diagn Microbiol Infect Dis 1997;27:49-53.
7. Gehanno P, Lenoir G, Berche P. In vivo correlates for S. pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother 1995;39:271-2.
8. Hoberman A, Paradise JL, Block S, Burch DJ, Jacobs MR, Balanescu MI. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. Pediatr Infect Dis J 1996;15:955-62.
9. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media in children (AOM) caused by intermediately penicillin-resistant pneumococci (I-PRP) [Abstract LB-25]. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1995.
10. SmithKline Beecham, data on file.
11. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin®) for treatment of acute otitis media in children. Pediatr Infect Dis J 1997;16:463-70.
12. Severin A, Severina E, Tomasz A. Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid. Antimicrob Agents Chemother 1997;41:504-10.
13. Seikel K, Shelton S, McCracken GH Jr. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J 1997;16:710-11.
14. Baquero F, Negri MC. Strategies to minimize the development of antibiotic resistance. J Chemother 1997;9(Suppl 3):29-37.